Cargando…
Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels
BACKGROUND: Rift Valley fever is an emerging zoonotic viral disease, enzootic and endemic in Africa and the Arabian Peninsula, which poses a significant threat to both human and animal health. The disease is most severe in ruminants causing abortions in pregnant animals, especially sheep animals and...
Autores principales: | Daouam, S., Ghzal, F., Naouli, Y., Tadlaoui, K. O., Ennaji, M. M., Oura, C., EL Harrak, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960673/ https://www.ncbi.nlm.nih.gov/pubmed/27457539 http://dx.doi.org/10.1186/s12917-016-0775-8 |
Ejemplares similares
-
Comparative thermo-stability of two Rift Valley fever virus vaccine candidate CL13T with a recombinant arMP-12ΔNSm21/384
por: Daouam, S, et al.
Publicado: (2020) -
In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Lumpy Skin disease viruses
por: Safini, N., et al.
Publicado: (2021) -
Rift Valley and West Nile Virus Antibodies in Camels, North Africa
por: El-Harrak, Mehdi, et al.
Publicado: (2011) -
Epidemiological surveillance of bovine viral diarrhea and rift valley fever infections in camel
por: El Bahgy, Halla E. K., et al.
Publicado: (2018) -
The Pathogenesis of Rift Valley Fever
por: Ikegami, Tetsuro, et al.
Publicado: (2011)